UnitedHealth Reaffirms 2025 Earnings Outlook Amid Stock Recovery
UnitedHealth Group (UNH) shares ROSE 1.5% in pre-market trading after the healthcare giant reiterated its 2025 adjusted EPS guidance of at least $16.00 per share. The reaffirmation comes ahead of investor meetings scheduled for September 2025, signaling management's confidence despite ongoing regulatory scrutiny.
The stock remains down 38% year-to-date, weighed by Medicare Advantage cost pressures and a DOJ probe into billing practices. July's updated forecast projects $445.5-$448 billion revenue, incorporating August's Amedisys acquisition which is expected to be marginally dilutive.